| Product Code: ETC7656941 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Neuroblastoma Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Neuroblastoma Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Neuroblastoma Market - Industry Life Cycle |
3.4 Israel Neuroblastoma Market - Porter's Five Forces |
3.5 Israel Neuroblastoma Market Revenues & Volume Share, By Diagnostics, 2021 & 2031F |
3.6 Israel Neuroblastoma Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.7 Israel Neuroblastoma Market Revenues & Volume Share, By End-User, 2021 & 2031F |
4 Israel Neuroblastoma Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about neuroblastoma diagnosis and treatment options in Israel |
4.2.2 Technological advancements in neuroblastoma diagnosis and therapy |
4.2.3 Growing investments in healthcare infrastructure and research for neuroblastoma |
4.3 Market Restraints |
4.3.1 High cost associated with neuroblastoma treatment and medications |
4.3.2 Limited availability of specialized healthcare professionals for neuroblastoma treatment in Israel |
5 Israel Neuroblastoma Market Trends |
6 Israel Neuroblastoma Market, By Types |
6.1 Israel Neuroblastoma Market, By Diagnostics |
6.1.1 Overview and Analysis |
6.1.2 Israel Neuroblastoma Market Revenues & Volume, By Diagnostics, 2021- 2031F |
6.1.3 Israel Neuroblastoma Market Revenues & Volume, By MIBG scan, 2021- 2031F |
6.1.4 Israel Neuroblastoma Market Revenues & Volume, By Imaging, 2021- 2031F |
6.1.5 Israel Neuroblastoma Market Revenues & Volume, By Biopsy, 2021- 2031F |
6.2 Israel Neuroblastoma Market, By Treatment |
6.2.1 Overview and Analysis |
6.2.2 Israel Neuroblastoma Market Revenues & Volume, By Surgery, 2021- 2031F |
6.2.3 Israel Neuroblastoma Market Revenues & Volume, By Medications, 2021- 2031F |
6.2.4 Israel Neuroblastoma Market Revenues & Volume, By Chemotherapy, 2021- 2031F |
6.2.5 Israel Neuroblastoma Market Revenues & Volume, By Radiation therapy, 2021- 2031F |
6.2.6 Israel Neuroblastoma Market Revenues & Volume, By Stem cell transplant, 2021- 2031F |
6.2.7 Israel Neuroblastoma Market Revenues & Volume, By Immunotherapy, 2021- 2031F |
6.3 Israel Neuroblastoma Market, By End-User |
6.3.1 Overview and Analysis |
6.3.2 Israel Neuroblastoma Market Revenues & Volume, By Hospitals and clinics, 2021- 2031F |
6.3.3 Israel Neuroblastoma Market Revenues & Volume, By Ambulatory surgical centers, 2021- 2031F |
6.3.4 Israel Neuroblastoma Market Revenues & Volume, By Diagnostic centers, 2021- 2031F |
6.3.5 Israel Neuroblastoma Market Revenues & Volume, By Research centers, 2021- 2031F |
6.3.6 Israel Neuroblastoma Market Revenues & Volume, By Others, 2021- 2031F |
7 Israel Neuroblastoma Market Import-Export Trade Statistics |
7.1 Israel Neuroblastoma Market Export to Major Countries |
7.2 Israel Neuroblastoma Market Imports from Major Countries |
8 Israel Neuroblastoma Market Key Performance Indicators |
8.1 Survival rates of neuroblastoma patients in Israel |
8.2 Number of clinical trials and research studies focused on neuroblastoma in Israel |
8.3 Adoption rate of new neuroblastoma treatment technologies in Israeli healthcare facilities |
9 Israel Neuroblastoma Market - Opportunity Assessment |
9.1 Israel Neuroblastoma Market Opportunity Assessment, By Diagnostics, 2021 & 2031F |
9.2 Israel Neuroblastoma Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.3 Israel Neuroblastoma Market Opportunity Assessment, By End-User, 2021 & 2031F |
10 Israel Neuroblastoma Market - Competitive Landscape |
10.1 Israel Neuroblastoma Market Revenue Share, By Companies, 2024 |
10.2 Israel Neuroblastoma Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here